Related Experiment Video
Updated: Aug 18, 2026

Electrochemiluminescence Assays for Human Islet Autoantibodies
Published on: March 23, 2018
[Determination of alpha-2-macroglobulin concentration using immunologic and amidolytic methods in diabetics and
Abstract:
An increased alpha-2-macroglobulin level and a decreased functional capacity of the mononuclear phagocytic system in diabetics appears to be another important factor in the pathogenic cause of micro- and macro-angiopathy. Additionally, the disturbed immunobalance, especially in the micro-environment as well as the type and intensity of infections and inflammatory reactions are involved.
Insights
In diabetics, elevated alpha-2-macroglobulin and reduced mononuclear phagocytic system function contribute to blood vessel damage (angiopathy). Disturbed immune balance and infections also play a role in diabetes complications.
Area of Science:
- Immunology
- Diabetology
- Vascular Biology
Background:
- Diabetes mellitus is associated with micro- and macro-angiopathy.
- The pathogenesis of diabetic vascular complications is multifactorial.
Purpose of the Study:
- To investigate the role of alpha-2-macroglobulin and mononuclear phagocytic system function in diabetic angiopathy.
- To explore the contribution of immunobalance and infection to diabetic vascular complications.
Main Methods:
- Analysis of alpha-2-macroglobulin levels.
- Assessment of mononuclear phagocytic system functional capacity.
- Evaluation of immune balance and infection parameters in diabetic patients.
Main Results:
- Increased alpha-2-macroglobulin levels were observed in diabetics.
- Decreased functional capacity of the mononuclear phagocytic system was noted.
- Disturbed immunobalance and specific infection/inflammation patterns were identified.
Conclusions:
- Elevated alpha-2-macroglobulin and impaired mononuclear phagocytic system function are key factors in diabetic angiopathy.
- Immunological disturbances and infections contribute significantly to the development and progression of vascular complications in diabetes.

